Integration of Functional Imaging, Cytometry, and Unbiased Proteomics Reveals New Features of Endothelial-to-Mesenchymal Transition in Ischemic Mitral Valve Regurgitation in Human Patients
Background: Following myocardial infarction, mitral regurgitation (MR) is a common complication. Previous animal studies demonstrated the association of endothelial-to-mesenchymal transition (EndMT) with mitral valve (MV) remodeling. Nevertheless, little is known about how MV tissue responds to isch...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-08-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2021.688396/full |
id |
doaj-1cca0143f9ba4ac497b9433d0b2e35c8 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Adrien Lupieri Yasufumi Nagata Livia S. A. Passos Dakota Beker-Greene Katherine A. Kirkwood Jill Wylie-Sears Zahra Alvandi Hideyuki Higashi Judy W. Hung Sasha A. Singh Joyce Bischoff Robert A. Levine Elena Aikawa Elena Aikawa Elena Aikawa |
spellingShingle |
Adrien Lupieri Yasufumi Nagata Livia S. A. Passos Dakota Beker-Greene Katherine A. Kirkwood Jill Wylie-Sears Zahra Alvandi Hideyuki Higashi Judy W. Hung Sasha A. Singh Joyce Bischoff Robert A. Levine Elena Aikawa Elena Aikawa Elena Aikawa Integration of Functional Imaging, Cytometry, and Unbiased Proteomics Reveals New Features of Endothelial-to-Mesenchymal Transition in Ischemic Mitral Valve Regurgitation in Human Patients Frontiers in Cardiovascular Medicine ischemic mitral regurgitation mitral valve endothelial-to-mesenchymal transition proteomics echocardiography histo-cytometry |
author_facet |
Adrien Lupieri Yasufumi Nagata Livia S. A. Passos Dakota Beker-Greene Katherine A. Kirkwood Jill Wylie-Sears Zahra Alvandi Hideyuki Higashi Judy W. Hung Sasha A. Singh Joyce Bischoff Robert A. Levine Elena Aikawa Elena Aikawa Elena Aikawa |
author_sort |
Adrien Lupieri |
title |
Integration of Functional Imaging, Cytometry, and Unbiased Proteomics Reveals New Features of Endothelial-to-Mesenchymal Transition in Ischemic Mitral Valve Regurgitation in Human Patients |
title_short |
Integration of Functional Imaging, Cytometry, and Unbiased Proteomics Reveals New Features of Endothelial-to-Mesenchymal Transition in Ischemic Mitral Valve Regurgitation in Human Patients |
title_full |
Integration of Functional Imaging, Cytometry, and Unbiased Proteomics Reveals New Features of Endothelial-to-Mesenchymal Transition in Ischemic Mitral Valve Regurgitation in Human Patients |
title_fullStr |
Integration of Functional Imaging, Cytometry, and Unbiased Proteomics Reveals New Features of Endothelial-to-Mesenchymal Transition in Ischemic Mitral Valve Regurgitation in Human Patients |
title_full_unstemmed |
Integration of Functional Imaging, Cytometry, and Unbiased Proteomics Reveals New Features of Endothelial-to-Mesenchymal Transition in Ischemic Mitral Valve Regurgitation in Human Patients |
title_sort |
integration of functional imaging, cytometry, and unbiased proteomics reveals new features of endothelial-to-mesenchymal transition in ischemic mitral valve regurgitation in human patients |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Cardiovascular Medicine |
issn |
2297-055X |
publishDate |
2021-08-01 |
description |
Background: Following myocardial infarction, mitral regurgitation (MR) is a common complication. Previous animal studies demonstrated the association of endothelial-to-mesenchymal transition (EndMT) with mitral valve (MV) remodeling. Nevertheless, little is known about how MV tissue responds to ischemic heart changes in humans.Methods: MVs were obtained by the Cardiothoracic Surgical Trials Network from 17 patients with ischemic mitral regurgitation (IMR). Echo-doppler imaging assessed MV function at time of resection. Cryosections of MVs were analyzed using a multi-faceted histology and immunofluorescence examination of cell populations. MVs were further analyzed using unbiased label-free proteomics. Echo-Doppler imaging, histo-cytometry measures and proteomic analysis were then integrated.Results: MVs from patients with greater MR exhibited proteomic changes associated with proteolysis-, inflammatory- and oxidative stress-related processes compared to MVs with less MR. Cryosections of MVs from patients with IMR displayed activated valvular interstitial cells (aVICs) and double positive CD31+ αSMA+ cells, a hallmark of EndMT. Univariable and multivariable association with echocardiography measures revealed a positive correlation of MR severity with both cellular and geometric changes (e.g., aVICs, EndMT, leaflet thickness, leaflet tenting). Finally, proteomic changes associated with EndMT showed gene-ontology enrichment in vesicle-, inflammatory- and oxidative stress-related processes. This discovery approach indicated new candidate proteins associated with EndMT regulation in IMR.Conclusion: We describe an atypical cellular composition and distinctive proteome of human MVs from patients with IMR, which highlighted new candidate proteins implicated in EndMT-related processes, associated with maladaptive MV fibrotic remodeling. |
topic |
ischemic mitral regurgitation mitral valve endothelial-to-mesenchymal transition proteomics echocardiography histo-cytometry |
url |
https://www.frontiersin.org/articles/10.3389/fcvm.2021.688396/full |
work_keys_str_mv |
AT adrienlupieri integrationoffunctionalimagingcytometryandunbiasedproteomicsrevealsnewfeaturesofendothelialtomesenchymaltransitioninischemicmitralvalveregurgitationinhumanpatients AT yasufuminagata integrationoffunctionalimagingcytometryandunbiasedproteomicsrevealsnewfeaturesofendothelialtomesenchymaltransitioninischemicmitralvalveregurgitationinhumanpatients AT liviasapassos integrationoffunctionalimagingcytometryandunbiasedproteomicsrevealsnewfeaturesofendothelialtomesenchymaltransitioninischemicmitralvalveregurgitationinhumanpatients AT dakotabekergreene integrationoffunctionalimagingcytometryandunbiasedproteomicsrevealsnewfeaturesofendothelialtomesenchymaltransitioninischemicmitralvalveregurgitationinhumanpatients AT katherineakirkwood integrationoffunctionalimagingcytometryandunbiasedproteomicsrevealsnewfeaturesofendothelialtomesenchymaltransitioninischemicmitralvalveregurgitationinhumanpatients AT jillwyliesears integrationoffunctionalimagingcytometryandunbiasedproteomicsrevealsnewfeaturesofendothelialtomesenchymaltransitioninischemicmitralvalveregurgitationinhumanpatients AT zahraalvandi integrationoffunctionalimagingcytometryandunbiasedproteomicsrevealsnewfeaturesofendothelialtomesenchymaltransitioninischemicmitralvalveregurgitationinhumanpatients AT hideyukihigashi integrationoffunctionalimagingcytometryandunbiasedproteomicsrevealsnewfeaturesofendothelialtomesenchymaltransitioninischemicmitralvalveregurgitationinhumanpatients AT judywhung integrationoffunctionalimagingcytometryandunbiasedproteomicsrevealsnewfeaturesofendothelialtomesenchymaltransitioninischemicmitralvalveregurgitationinhumanpatients AT sashaasingh integrationoffunctionalimagingcytometryandunbiasedproteomicsrevealsnewfeaturesofendothelialtomesenchymaltransitioninischemicmitralvalveregurgitationinhumanpatients AT joycebischoff integrationoffunctionalimagingcytometryandunbiasedproteomicsrevealsnewfeaturesofendothelialtomesenchymaltransitioninischemicmitralvalveregurgitationinhumanpatients AT robertalevine integrationoffunctionalimagingcytometryandunbiasedproteomicsrevealsnewfeaturesofendothelialtomesenchymaltransitioninischemicmitralvalveregurgitationinhumanpatients AT elenaaikawa integrationoffunctionalimagingcytometryandunbiasedproteomicsrevealsnewfeaturesofendothelialtomesenchymaltransitioninischemicmitralvalveregurgitationinhumanpatients AT elenaaikawa integrationoffunctionalimagingcytometryandunbiasedproteomicsrevealsnewfeaturesofendothelialtomesenchymaltransitioninischemicmitralvalveregurgitationinhumanpatients AT elenaaikawa integrationoffunctionalimagingcytometryandunbiasedproteomicsrevealsnewfeaturesofendothelialtomesenchymaltransitioninischemicmitralvalveregurgitationinhumanpatients |
_version_ |
1721209740748390400 |
spelling |
doaj-1cca0143f9ba4ac497b9433d0b2e35c82021-08-12T05:46:57ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2021-08-01810.3389/fcvm.2021.688396688396Integration of Functional Imaging, Cytometry, and Unbiased Proteomics Reveals New Features of Endothelial-to-Mesenchymal Transition in Ischemic Mitral Valve Regurgitation in Human PatientsAdrien Lupieri0Yasufumi Nagata1Livia S. A. Passos2Dakota Beker-Greene3Katherine A. Kirkwood4Jill Wylie-Sears5Zahra Alvandi6Hideyuki Higashi7Judy W. Hung8Sasha A. Singh9Joyce Bischoff10Robert A. Levine11Elena Aikawa12Elena Aikawa13Elena Aikawa14Division of Cardiovascular Medicine, Center for Excellence in Vascular Biology and Harvard Medical School, Brigham and Women's Hospital, Boston, MA, United StatesCardiac Ultrasound Laboratory and Harvard Medical School, Massachusetts General Hospital, Boston, MA, United StatesDivision of Cardiovascular Medicine, Center for Excellence in Vascular Biology and Harvard Medical School, Brigham and Women's Hospital, Boston, MA, United StatesDivision of Cardiovascular Medicine, Center for Excellence in Vascular Biology and Harvard Medical School, Brigham and Women's Hospital, Boston, MA, United StatesDepartment of Population Health Science and Policy, Icahn School of Medicine, International Center for Health Outcomes and Innovation Research, New York, NY, United StatesVascular Biology Program and Department of Surgery, Boston Children's Hospital and Department of Surgery and Harvard Medical School, Boston, MA, United StatesVascular Biology Program and Department of Surgery, Boston Children's Hospital and Department of Surgery and Harvard Medical School, Boston, MA, United StatesDivision of Cardiovascular Medicine, Center for Interdisciplinary Cardiovascular Sciences and Harvard Medical School, Brigham and Women's Hospital, Boston, MA, United StatesEchocardiography Laboratory, Division of Cardiology and Harvard Medical School, Massachusetts General Hospital, Boston, MA, United StatesDivision of Cardiovascular Medicine, Center for Interdisciplinary Cardiovascular Sciences and Harvard Medical School, Brigham and Women's Hospital, Boston, MA, United StatesVascular Biology Program and Department of Surgery, Boston Children's Hospital and Department of Surgery and Harvard Medical School, Boston, MA, United StatesCardiac Ultrasound Laboratory and Harvard Medical School, Massachusetts General Hospital, Boston, MA, United StatesDivision of Cardiovascular Medicine, Center for Excellence in Vascular Biology and Harvard Medical School, Brigham and Women's Hospital, Boston, MA, United StatesDivision of Cardiovascular Medicine, Center for Interdisciplinary Cardiovascular Sciences and Harvard Medical School, Brigham and Women's Hospital, Boston, MA, United StatesDepartment of Human Pathology, Sechenov First Moscow State Medical University, Moscow, RussiaBackground: Following myocardial infarction, mitral regurgitation (MR) is a common complication. Previous animal studies demonstrated the association of endothelial-to-mesenchymal transition (EndMT) with mitral valve (MV) remodeling. Nevertheless, little is known about how MV tissue responds to ischemic heart changes in humans.Methods: MVs were obtained by the Cardiothoracic Surgical Trials Network from 17 patients with ischemic mitral regurgitation (IMR). Echo-doppler imaging assessed MV function at time of resection. Cryosections of MVs were analyzed using a multi-faceted histology and immunofluorescence examination of cell populations. MVs were further analyzed using unbiased label-free proteomics. Echo-Doppler imaging, histo-cytometry measures and proteomic analysis were then integrated.Results: MVs from patients with greater MR exhibited proteomic changes associated with proteolysis-, inflammatory- and oxidative stress-related processes compared to MVs with less MR. Cryosections of MVs from patients with IMR displayed activated valvular interstitial cells (aVICs) and double positive CD31+ αSMA+ cells, a hallmark of EndMT. Univariable and multivariable association with echocardiography measures revealed a positive correlation of MR severity with both cellular and geometric changes (e.g., aVICs, EndMT, leaflet thickness, leaflet tenting). Finally, proteomic changes associated with EndMT showed gene-ontology enrichment in vesicle-, inflammatory- and oxidative stress-related processes. This discovery approach indicated new candidate proteins associated with EndMT regulation in IMR.Conclusion: We describe an atypical cellular composition and distinctive proteome of human MVs from patients with IMR, which highlighted new candidate proteins implicated in EndMT-related processes, associated with maladaptive MV fibrotic remodeling.https://www.frontiersin.org/articles/10.3389/fcvm.2021.688396/fullischemic mitral regurgitationmitral valveendothelial-to-mesenchymal transitionproteomicsechocardiographyhisto-cytometry |